KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Share-based Compensation (2016 - 2025)

Fulgent Genetics' Share-based Compensation history spans 10 years, with the latest figure at $9.3 million for Q4 2025.

  • For Q4 2025, Share-based Compensation fell 10.88% year-over-year to $9.3 million; the TTM value through Dec 2025 reached $39.6 million, down 11.01%, while the annual FY2025 figure was $39.6 million, 11.01% down from the prior year.
  • Share-based Compensation for Q4 2025 was $9.3 million at Fulgent Genetics, down from $9.7 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $11.6 million in Q2 2024 and bottomed at $3.0 million in Q1 2021.
  • The 5-year median for Share-based Compensation is $10.0 million (2022), against an average of $8.8 million.
  • The largest annual shift saw Share-based Compensation surged 226.48% in 2021 before it fell 13.72% in 2025.
  • A 5-year view of Share-based Compensation shows it stood at $5.0 million in 2021, then surged by 99.64% to $10.0 million in 2022, then grew by 14.07% to $11.4 million in 2023, then fell by 8.96% to $10.4 million in 2024, then fell by 10.88% to $9.3 million in 2025.
  • Per Business Quant, the three most recent readings for FLGT's Share-based Compensation are $9.3 million (Q4 2025), $9.7 million (Q3 2025), and $10.0 million (Q2 2025).